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Primary cutaneous cribriform
carcinoma: report of six cases with
clinicopathologic data and
immunohistochemical profile
Background: Primary cutaneous cribriform carcinoma (PCCC) is
a rare and under-recognized variant of sweat gland carcinoma,
characterized by anastomosing tubules and solid nests producing
a sieve-like appearance.
Methods: Six cases of PCCC were clinically, histopathologically
and immunophenotypically studied.
Results: All cases showed an unencapsulated, nodular dermal
tumor composed of solid and cribriform nests, cords and tubules
embedded within a desmoplastic stroma. Some tubules showed
micropapillary projections reminiscent of tubular adenoma, and
intraluminal thin bridges resembling adenomatoid tumor. One
case showed a predominantly solid component. Only two cases
showed very focal decapitation secretion. Tumor cells expressed
CK7, CK5/6, EMA, CEA, S-100, BerEP4 and c-kit and were
negative for cytokeratin 20, estrogen receptor/progesterone
receptor (ER/PR), androgen receptor and GCDFP-15. Calponin,
p63 and smooth muscle actin (SMA) showed absence of a
myoepithelial layer.
Conclusions: Contrary to the original reports, our series shows
that PCCC may be predominantly solid with only a minor
cribriform component, and expresses c-kit and S-100 which may
potentially lead to the misdiagnosis of adenoid cystic carcinoma.
Immunohistochemical stains may aid in distinction from tubular
adenoma. Current data suggest a favorable outcome, as metastatic
disease has not been reported to date.
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Primary cutaneous cribriform carcinoma
(PCCC) is a rare variant of sweat gland car-
cinoma with unique histopathologic features,
first described in 1998 by Requena et al.1 In
this initial report, five patients presented with
solitary skin nodules, most commonly affecting
the extremities. Histopathologically, PCCC is
characterized by anastomosing nests of neoplas-
tic cells that form cribriform spaces, imparting
a sieve-like appearance. Requena et al. regarded
PCCC as an apocrine neoplasm based on the
observation of decapitation secretion in the
neoplastic cells. Following two case reports,2,3
Rütten et al.4 published the largest series to date
of 26 cases, which supported Requena’s original
clinicopathologic impression and contributed to
the evidence that PCCC behaves in an indolent
fashion.
We present our experience with six additional
cases of PCCC. Our cases highlight a spectrum of
histomorphology not described in the original
report. We also detail an expanded immuno-
histochemical characterization of PCCC not
previously reported. Finally, a discussion on
its differential diagnosis, potential diagnostic
pitfalls and clinical considerations is provided.
Material and methods
This series was compiled from cases seen in
consultation at the University of Michigan as
well as the personal slide collections of AAA and
MPC. Clinical information was obtained from
contributing clinicians as well as a search of the
patient’s medical record where available.
The following immunohistochemical stains
were performed on four available cases of
PCCC: CK5/6 (predilute: mouse monoclonal
D5/16B4), S-100 (predilute: rabbit polyclonal),
EMA (predilute: mouse monoclonal, E29),
ER (predilute: rabbit monoclonal SP1), PR
(predilute: rabbit monoclonal 1E2), calponin
(predilute: rabbit monoclonal EP798Y), smooth
muscle actin (SMA) (predilute: mouse mon-
oclonal 1A4) and p63 (predilute: mouse
monoclonal 4A4) from Ventana Medical Sys-
tems (Tucson, AZ, USA); CK7 (1/100; mouse
monoclonal OV-TL 12/30), CK20 (1/200:
mouse monoclonal Ks20.8), c-kit (1/100: rabbit
monoclonal YR145) and BRST-2 (predilute;
rabbit monoclonal EP1582Y) from Cell Marque
(Rocklin, CA, USA); BerEp4 (1/100: mouse
monoclonal) and CEA (1/1000: rabbit poly-
clonal) from Dako (Glostrup, Denmark).
Staining was performed on formalin-fixed
paraffin embedded sections using the Ventana
Benchmark Ultra automated immunostainer
according to standard protocols validated by
the Immunoperoxidase Laboratory within
the Department of Pathology at (removed
for review). Selected immunohistochemical
stains were also performed on a representative
case of tubular adenoma retrieved from the
department files.
Results
Clinicopathologic data is summarized in Table 1.
Of the six cases studied, genders were equally
represented. The average age at presentation
was 43-year-old (range: 31–61 years). Tumors
were limited to the extremities, including three
from the arm and three from the leg. Clini-
cal diagnosis was available for three cases and
included: tender epidermal inclusion cyst, der-
matofibroma and a mobile nodule. All patients
underwent conservative excision with negative
margins. Pathologic size ranged 4–12mm (aver-
age: 6.5mm). Sentinel lymph node biopsies were
performed in two cases, both of which were
negative. Follow-up data was available in two
cases with no evidence of recurrence at 16 and
22months, respectively.
From a histopathologic perspective, the six
cases of PCCC showed a unifying constellation
of features. All cases showed a partially cir-
cumscribed, unencapsulated, dermal nodule
composed of epithelial nests with lumen forma-
tion set in a desmoplastic stroma (Fig. 1). In four
cases the tumor showed a pushing border into
the subcutaneous fat; the remaining two cases
were limited to the dermis. Many nests anas-
tomosed or interconnected with neighboring
nests. Invariably, neoplastic lumina and intra-
luminal bridges were composed of markedly
attenuated epithelium producing a sieve-like
appearance at low magnification. These
sieve-like spaces varied in size throughout the
same tumor, ranging from small to quite dilated
(Fig. 2A). Small intraluminal micropapillae
were also be appreciated. Scattered eosinophilic
secretions were present in a minority of lumina.
The tumor nests were composed of epithe-
lioid cells with round to polygonal, hyperchro-
matic nuclei, occasional small nucleoli and scant
to moderate amount of dense eosinophilic cyto-
plasm. The cells lining the luminal spaces and
producing the intraluminal bridges ranged from
cuboidal to markedly flattened, with elongated
nuclei. Areas of attenuation were one or several
layers thick, however there was no appreciable
myoepithelial layer. Decapitation secretion was
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Table 1. Clinicopathologic features of PCCC
Clinical features
Age 41 32 35 59 61 31
Gender F F M F M M
Location Leg Elbow Leg Arm Arm Leg
Clinical impression EIC, tender NA NA NA Mobile nodule DF
SNL status (if performed) 0/1 0/2
Recurrence NTD NA NTD NA NA NA
Histopathology
Pathologic size (mm) 6 5 5 4 7 12
Solid/tubular% 40/60% 10/90% 50/50% 95/5% 60/40% 5/95%
Desmoplastic stroma Yes Yes Yes Yes Yes Yes
Single cells at periphery Yes Yes Yes Yes Yes Yes
Lymphoid aggregates Yes No Yes Yes Yes Yes
Decapitation secretion Focal No No No No Focal
Lymphovascular/neural invasion No No No No No No
F, female; M, male; NA, data not available; SLN, sentinel lymph node; NTD, none to date; EIC, epidermal inclusion cyst; DF, dermatofibroma.
Fig. 1. Primary cutaneous cribriform carcinoma. On low magnification, the tumor forms a relatively well-circumscribed, unencap-
sulated dermal nodule. The majority of primary cutaneous cribriform carcinomas (PCCCs) appear sieve-like because of numerous
dilated cystic spaces [A: hematoxylin and eosin (H&E), ×20]. However, PCCC may also show areas of solid growth admixed with
cystic spaces (B: H&E, ×15), or less commonly be composed of predominantly solid nests (C: H&E, ×15).
focally present in two cases and absent in the
remaining cases (Fig. 2B). In situ lesions, such as
apocrine hyperplasia or ductal carcinoma in situ,
were absent. Infrequent mitoses were identified
(range: 1–3 mitoses per 10 fields at ×400) as well
as occasional, scattered single cell necrosis.
The ratio of solid nests compared to lumen
formation varied dramatically among the six
examples. In one case, 95% of tumor nests
showed lumen formation with the remaining
5% showing solid growth. In contrast, another
case was predominantly solid with only 5% of
the tumor nests forming characteristic dilated
lumens with attenuated lining epithelium
(Fig. 3). With limited lumen formation, this
case did not show the characteristic sieve-like,
cribriform appearance. The remaining cases
contained a roughly equal proportion of tubular
and solid components.
On close inspection of the periphery of the
neoplasms, rare scattered infiltrative single cells
were appreciated in all cases. These cells were
embedded in the desmoplastic stroma associ-
ated with the tumor, and did not extend beyond
1mm from the main tumor mass. No lympho-
vascular or perineural invasion was identified.
There was no connection between the neoplastic
nests and the overlying, unremarkable epidermis
or existing adnexal structures. Lymphoid aggre-
gates were present at the periphery of five cases.
Immunohistochemical stains were performed
on four cases of PCCC and one case of tubu-
lar adenoma with results summarized in Table 2.
The tumor cells were strongly and diffusely
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Fig. 2. Histomorphologic features of primary cutaneous cribriform carcinoma. Dilated cystic spaces with markedly attenuated
epithelium. Within some of those spaces are intraluminal micropapillae and intraluminal bridges imparting a cribriform growth
pattern [A: hematoxylin and eosin (H&E), ×100x]. Focal areas suggestive of decapitation secretion were present in two of six cases
of PCCC (B: H&E, 200x).
Fig. 3. Predominantly solid variant of primary cutaneous crib-
riform carcinoma with focal attenuated luminal epithelium,
bridging and micropapillae [hematoxylin and eosin (H&E),
×80].
immunoreactive for CK5/6 and CK7 while nega-
tive for CK20. S-100 was also positive in all cases
in a patchy to diffuse pattern (Fig. 4A). CEA
and EMA staining demonstrated luminal posi-
tivity. C-kit (CD117, Fig. 4B) and BerEp4 were
also positive. BRST-2 and ER/PR were negative
in all cases in which these stains were performed.
Calponin and SMA highlighted myofibroblasts
within the desmoplastic stroma. Staining for
p63 highlighted rare, scattered neoplastic cells
within the tumor nests. There was no evidence
of a myoepithelial layer on either hematoxylin
Table 2. Immunohistochemical profile of primary cutaneous cribri-
form carcinoma (PCCC) and tubular adenoma (TA)
PCCC TA
CK5/6 + NA + + +
CK7 + + + + +
CK20 − − NA − −
S100 + + + (patchy) + + (rare)
CEA +luminal +luminal NA +luminal NA
EMA +luminal +luminal NA +luminal NA
C-kit + NA + + (patchy) + (patchy)
BerEp4 + NA + + +
BRST-2 − NA − − −
ER/PR − − NA − NA
Calponin +stroma NA NA +stroma +myoepi
SMA +stroma NA +stroma +stroma +myoepi
p63 + (rare) NA + (rare) + (rare) +myoepi
NA, data not available; myoepi, myoepithelial layer;+,>50% of tumor
cells are positive; patchy, 25–50% of tumor cell are positive; rare,
<1% of tumor cells are positive.
and eosin-stained sections or by immunohisto-
chemistry with p63, SMA and calponin (Fig. 5).
The control case of tubular adenoma included
in the study showed rare S-100 positive cells
(<1% of cells), patchy immunoreactivity for c-kit
(25–50% of cells), and a conspicuous myoep-
ithelial layer positive with p63, SMA and calponin
was noted (Fig. 6).
Discussion
PCCC is a rare variant of sweat gland carcinoma.
The clinical presentations and outcomes of
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Fig. 4. Primary cutaneous cribriform carcinoma shows diffuse immunostaining for S-100 (A: ×200) andmembranous c-kit (B: ×200)
positivity.
Fig. 5. Primary cutaneous cribriform carcinoma is negative for
a myoepithelial layer by calponin immunostain (×200).
PCCCs from this study and previous reports
are summarized in Table 3. The neoplasm
presents as a solitary dermal nodule without
overlying epidermal changes. Aggregating all
data available on PCCC,1–4 women are more
frequently affected (2 : 1 female to male ratio),
with an average age of 47 years. To date there
has been no report of recurrence or metastases.
Requena et al. reported persistence at the site
secondary to incomplete excision.1 Unlike the
original description of PCCC,1 in which ‘the
entire neoplasm has a cribriform pattern,’ our
series contains one case that is predominantly
solid. Recognition of this spectrum of histomor-
phology is important, as other carcinomas such
as adenoid cystic carcinoma (ACC) may also
show a predominantly solid pattern. ACC has a
propensity for perineural invasion, recurrence
and metastasis in some cases,5–10 none of which
have been observed in PCCC. In our one case
with predominantly solid nests (Fig. 3), few
foci toward the periphery displayed a more
characteristic appearance including attenuated
luminal epithelium and thread-like intraluminal
bridges, supporting the diagnosis of PCCC.
Several authors considered PCCC to be an
apocrine adenocarcinoma based on the finding
of decapitation secretion.1,2 Apocrine adeno-
carcinoma is a broad category, encompassing
several defined entities such as digital papillary
adenocarcinoma, syringocystadenocarcinoma
papilliferum and malignant apocrine mixed
tumor.11 However, when histopathologic criteria
are not met for these entities, the diagnosis
of apocrine carcinoma not-otherwise-specified
(NOS) may be rendered, thus resulting in a
heterogeneous group of carcinomas. In such
cases, decapitation secretion or cytoplasmic
zymogen granules are generally regarded as
evidence of apocrine differentiation. Addition-
ally, in situ precursor lesions may be observed
in these tumors,12–16 although a larger series
suggests that these are uncommon.17 In situ
lesions are analogous to those routinely seen in
breast pathology, namely, columnar cell change,
usual ductal hyperplasia, atypical ductal hyper-
plasia and ductal carcinoma in situ.11 Apocrine
differentiation may be appreciated in these
precursor lesions. Staining for myoepithelial
markers such as calponin, p63 and SMA can
help distinguish in situ lesions from the invasive
component.
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Fig. 6. Tubular adenoma may have similar histopathologic findings to primary cutaneous cribriform carcinoma, including dilated
cystic spaces with attenuated epithelium, micropapillae, and focal intraluminal bridging. The stroma is paucicellular and fibrous
(A: hematoxylin and eosin (H&E), ×100). Calponin immunostain highlights the myoepithelial layer surrounding nests in tubular
adenoma (B; 200x).
Table 3. Clinical presentations and outcomes of PCCC reported in the literature and in this study
Sex (number of cases) Average age (range) Location Available follow up
Requena et al.1 * 44 years (20–55) 3 lower ext. 2 cases persisted at site secondary
1 upper ext. to incomplete excision. No
1 pubis metastases.
Rütten et al.4 F (19) 47.8 years (23–77) 10 lower ext. 13 cases with no recurrence or
M (7) 9 upper ext. metastases after re-excision.
4 trunk
1 head
1 neck
Adamski et al.2 M 37 years lower ext. No recurrence or metastases.
Fernandez-Flores et al.3 F 62 years lower ext. No recurrence or metastases.
Current report F (3) 43 years (31–61) 3 lower ext. 2 cases with no recurrence or
M (3) 3 upper ext. metastases.
Summary of reported data F (23; 67%) 47 years (20–77) 18 lower ext. (47%) 2 cases persisted at site secondary
M (11; 32%) 13 upper ext. (34%) to incomplete excision. No cases
4 trunk (10%) with recurrence or metastases.
1 head (3%)
1 neck (3%)
1 pubis (3%)
F, female; M, male; ext., extremity.
*Reported as ‘mainly women.’
Some authors have questioned the apocrine
derivation of PCCC.3 In our series, we appre-
ciated only very focal decapitation secretion in
two cases. Close inspection of the tumors and
the surrounding adnexal structures in conjunc-
tion with immunohistochemistry showed no
in situ lesions. Similarly, no previous reports
of PCCC have described an in situ component
to our knowledge. Furthermore, the lack of
staining for BRST-2 (GCDFP-15) in our series
also provides some evidence against apocrine
differentiation.18,19 Unlike most other apocrine
carcinomas which have a propensity to occur in
the axilla or anogenital region, PCCC does not
appear to follow this distribution but instead
shows a predilection for the extremities. The
true derivation of PCCC therefore remains
uncertain.
Our study presents a new finding of membra-
nous c-kit (CD117) immunoreactivity in PCCC
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Fig. 7. Adenoid cystic carcinoma is arranged in discrete lobules
and demonstrates basophilic mucinous material within cystic
spaces [hematoxylin and eosin (H&E), ×100].
(Fig. 4B). This raises a potential diagnostic pit-
fall, namely confusion with ACC, either primary
cutaneous or metastatic, which is also positive for
c-kit.5,20 ACC typically shows a mixture of cribri-
form and solid growth patterns. However, unlike
PCCC, ACC is poorly circumscribed with infil-
trative growth. ACC is arranged in discrete lob-
ules, demonstrates basophilic mucinousmaterial
within cystic spaces, and lacks the characteristic
marked epithelial attenuation and intraluminal
micropapillae seen in PCCC (Fig. 7). The finding
of perineural invasion should raise concern for
ACC, as ACC is notoriously neurotropic, whereas
perineural invasion has not been reported in
PCCC. ACC is also typically S-100 positive.5,11,21
The majority of previous reports have described
negative staining for S-100 in PCCC.2–4 How-
ever, we found S-100 to be positive in all our
cases of PCCC in which the stain was performed
(Fig. 4A), ranging from diffuse (three cases) to
patchy (one case).
In ours and other investigators experience,22
PCCC most closely resembles tubular adenoma.
The World Health Organization (WHO) classi-
fies both papillary eccrine adenoma and tubular
apocrine adenoma as tubular adenoma.23 As
PCCC is currently regarded as a low-grade car-
cinoma, distinction from tubular adenoma is
clinically relevant. The microscopic features of
tubular adenoma are variable and may overlap
with those of PCCC (Fig. 6). For example, tubu-
lar adneoma may be composed of dilated cystic
spaces lined by markedly attenuated epithelium,
similar to those observed in PCCC. It may also
display micropapillae and focal intraluminal
bridging. In contrast to PCCC which is invariably
set in a desmoplastic stroma, tubular adenoma
typically shows a paucicellular fibrous stroma.
Interestingly, decapitation secretion in tubu-
lar adenoma is far more conspicuous than in
PCCC. Key to the distinction is the recognition
of a myoepithelial layer in tubular adenoma,
which is lacking in PCCC. In areas of markedly
attenuated epithelium this may be difficult to
appreciate, however tubular adenoma typically
has scattered glands in which a continuous outer
myoepithelial layer can be appreciated on hema-
toxylin and eosin-stained sections. In smaller
biopsies, however, recognition of myoepithelium
and other subtle features may be challenging.
In such cases, immunohistochemical stains
for myoepithelium such as p63, calponin or
Fig. 8. Eccrine carcinoma of the scalp with clear cell change in the dermis and a second population of deeper infiltrative glands
demonstrating many of the features of PCCC [A: hematoxylin and eosin (H&E), ×50]. Nests are composed of dilated spaces lined
by markedly attenuated with occasional thread-like intraluminal bridges and micropapillae (B: H&E, ×100).
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SMA may be helpful. The tumor nests in PCCC
consistently lack a myoepithelial layer, with
myoepithelial immunostains highlighting only
a subset of stromal myofibroblasts (Fig. 5). In
contrast, the glands of tubular adenoma are
surrounded by a single layer of myoepithelial
cells highlighted by either p63, calponin or SMA
(Fig. 6). Even in areas of marked attenuation, at
least a subset of the glands will exhibit myoep-
ithelial staining. In our experience, calponin
or p63 immunostaining show less background
staining of stromal myofibroblasts and thus may
be easier to interpret.
Another pathologic mimic of PCCC is the
mesothelial-derived adenomatoid tumor.24
Interestingly, Crippa et al. reported a skin
tumor closely resembling adenomatoid tumor,
which was negative for mesothelial markers
by immunohistochemistry.25 As Kazakov et al.
noted, this may very well have been an example
of PCCC.22 One may also consider the possibility
of cribriform-patterned metastasis from other
sites such as the breast, salivary gland, colon,
prostate, uterus or ovaries. Close inspection
would probably reveal microscopic features
divergent from PCCC, such as a cribriform
appearance but lacking thread-like intraluminal
bridges, or the presence of high-grade cytomor-
phology or dirty necrosis. Immunohistochemical
stains such as BRST-2, ER, PR, CK20, CDX-2,
PSA and PAX-8 may be helpful in supporting
the diagnosis of metastasis and in determining
the site of origin.
It is also important to note that tumors with
features of eccrine carcinoma or syringomatous
carcinoma (both whichmay be variants of micro-
cystic adnexal carcinoma)may occasionally show
focal areas with features of PCCC.11 We have
recently encountered a consultation such a case
of eccrine carcinoma of the scalp with clear cell
change with a second population of deeper infil-
trative glands showing many of the features of
PCCC (Fig. 8) The tumor nests were composed
of dilated spaces lined by markedly attenuated
epithelium with occasional thread-like intralu-
minal bridges and micropapillae. However, the
overall pattern of infiltration is not in keeping
with PCCC, this example of eccrine carcinoma
was broadly infiltrative, not a nodular prolif-
eration. Whereas clear cell change has been
described previously in eccrine carcinoma,26,27
it is not a feature of PCCC.
In summary, we report the unique clinico-
pathologic features of PCCC. As opposed to
the original reports, our cases showed that
PCCC may be predominantly solid with only a
minor cribriform component. We also demon-
strated that PCCC expresses c-kit and S-100 by
immunohistochemistry, a potential pitfall in its
differentiation from ACC. Tubular adenoma can
be distinguished from PCCC by the presence of
a myoepithelial layer around the tumor nests.
PCCC is currently regarded as a low-grade car-
cinoma and appears to behave in an indolent
fashion; treatment is complete excision.
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